Ester Orlandi

7.7k total citations · 1 hit paper
241 papers, 4.0k citations indexed

About

Ester Orlandi is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ester Orlandi has authored 241 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Otorhinolaryngology, 88 papers in Pulmonary and Respiratory Medicine and 86 papers in Surgery. Recurrent topics in Ester Orlandi's work include Head and Neck Cancer Studies (88 papers), Head and Neck Surgical Oncology (44 papers) and Advanced Radiotherapy Techniques (38 papers). Ester Orlandi is often cited by papers focused on Head and Neck Cancer Studies (88 papers), Head and Neck Surgical Oncology (44 papers) and Advanced Radiotherapy Techniques (38 papers). Ester Orlandi collaborates with scholars based in Italy, France and Germany. Ester Orlandi's co-authors include Paolo Bossi, Lisa Licitra, Mario Lazzarino, Ercole Brusamolino, Laura D. Locati, C. Fallai, Luca Arcaini, Nicola Alessandro Iacovelli, Mario Cazzola and Cristiana Pascutto and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Ester Orlandi

218 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

2020 240 citations Paolo Bossi, Lisa Licitra et al. profile →

Peers

Countries citing papers authored by Ester Orlandi

Since Specialization

Citations

This map shows the geographic impact of Ester Orlandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Orlandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Orlandi more than expected).

Fields of papers citing papers by Ester Orlandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Orlandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Orlandi. The network helps show where Ester Orlandi may publish in the future.

Co-authorship network of co-authors of Ester Orlandi

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Orlandi. A scholar is included among the top collaborators of Ester Orlandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Orlandi. Ester Orlandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study 2025 ·European Journal of Cancer ·Salvatore Alfieri, (unknown), Sara Marceglia, (unknown), (unknown), (unknown), (unknown), (unknown), Stefano Cavalieri, Cristiana Bergamini, Elena Colombo, (unknown), Loris De Cecco, (unknown), Nicola Alessandro Iacovelli, Marco Guzzo, Ester Orlandi, Laura D. Locati, Paolo Bossi, Lisa Licitra, Francesca Taverna	0
2	Charged particle radiotherapy for thyroid cancer. A systematic review 2024 ·Critical Reviews in Oncology/Hematology ·Lucia Pia Ciccone, (unknown), Maria Bonora, Sara Ronchi, (unknown), (unknown), Angelica Facoetti, (unknown), Giuseppe Magro, Barbara Vischioni, Laura D. Locati, Lisa Licitra, W. Sauerwein, Ester Orlandi	0
3	Vaginal Mucosal Melanoma Cell Activation in Response to Photon or Carbon Ion Irradiation 2024 ·International Journal of Particle Therapy ·(unknown), Amelia Barcellini, (unknown), Gilles Ivaldi, Sara Lillo, Giuseppe Magro, Ester Orlandi, M. Pullia, Sara Ronchi, (unknown), Angelica Facoetti	4
4	Setup Optimization in Ocular Proton Therapy at the National Centre for Oncological Hadrontherapy: Comparison of Two Approaches to Refine the Position of an Eye-Tracking Device 2024 ·Applied Sciences ·(unknown), Andrea Pella, Matteo Pepa, Federica Galante, Mario Ciocca, Maria Rosaria Fiore, (unknown), Chiara Paganelli, (unknown), Alessandro Vai, Ester Orlandi, G. Baroni	0
5	Proton Therapy in Non-Rhabdomyosarcoma Soft Tissue Sarcomas of Children and Adolescents 2024 ·Cancers ·Sabina Vennarini, Francesca Colombo, Alfredo Mirandola, Ester Orlandi, Emilia Pecori, Stefano Chiaravalli, Maura Massimino, Michela Casanova, Andrea Ferrari	0
6	Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 2024 ·Cancers ·(unknown), Amelia Barcellini, Andrea Peloso, Alessandro Vanoli, Stefania Cesari, Antonia Icaro Cornaglia, (unknown), Stefania Croce, Lorenzo Cobianchi, Gilles Ivaldi, Laura D. Locati, Giuseppe Magro, (unknown), M. Pullia, Ester Orlandi, Angelica Facoetti	4
7	Developing a trial design to establish BNCT as clinical application: insight for the national italian center for oncological hadrontherapy (CNAO) 2024 ·Health and Technology ·Lisa Licitra, Stefano Cavalieri, Carmine Tinelli, (unknown), Ester Orlandi	0
8	Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 2024 ·Tumori Journal ·Amelia Barcellini, Chiara Cassani, Ester Orlandi, Rossella E. Nappi, (unknown), (unknown), Silvia Molinelli, (unknown), Viviana Vitolo, Alessandro Gronchi, Gioacchino D’Ambrosio, Lorenzo Cobianchi, Maria Rosaria Fiore	1
9	Synthetic CT in Carbon Ion Radiotherapy of the Abdominal Site 2023 ·Bioengineering ·(unknown), Alessandro Vai, (unknown), (unknown), (unknown), (unknown), Silvia Molinelli, Amelia Barcellini, Andrea Pella, Mario Ciocca, Viviana Vitolo, Ester Orlandi, Chiara Paganelli, G. Baroni	11
10	Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 2023 ·Cancers ·Amelia Barcellini, Andrei Fodor, (unknown), Chiara Cassani, Laura D. Locati, Raffaella Cioffi, Alice Bergamini, Sandro Pignata, Ester Orlandi, Giorgia Mangili	2
11	Gynecological radio-induced secondary malignancy after a gynecological primary tumor: a rare entity and a challenge for oncologists 2022 ·International Journal of Gynecological Cancer ·Amelia Barcellini, Mattia Dominoni, Bárbara Gardella, Giorgia Mangili, Ester Orlandi	3
12	A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients 2022 ·Cancers ·Alfredo Mirandola, Stefania Russo, Maria Bonora, Barbara Vischioni, (unknown), Rossana Ingargiola, Silvia Molinelli, Sara Ronchi, (unknown), Alessandro Vai, Nicola Alessandro Iacovelli, Juliette Thariat, Mario Ciocca, Ester Orlandi	9
13	Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision 2022 ·Cancers ·Alessandro Vai, Silvia Molinelli, (unknown), Nicola Alessandro Iacovelli, Giuseppe Magro, Anna Cavallo, E. Pignoli, T. Rancati, Alfredo Mirandola, Stefania Russo, Rossana Ingargiola, Barbara Vischioni, Maria Bonora, Sara Ronchi, Mario Ciocca, Ester Orlandi	16
14	Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy 2022 ·Future Oncology ·Giulia Fontana, Amelia Barcellini, (unknown), (unknown), Pierre Loap, Lorenzo Cobianchi, Viviana Vitolo, Maria Rosaria Fiore, Alessandro Vai, G. Baroni, Lorenzo Preda, (unknown), Ester Orlandi	1
15	Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 2022 ·Critical Reviews in Oncology/Hematology ·Amelia Barcellini, Giorgia Mangili, Andrei Fodor, (unknown), (unknown), (unknown), Sandro Pignata, Ester Orlandi, Alice Bergamini	5
16	Hadrontherapy techniques for breast cancer 2021 ·Critical Reviews in Oncology/Hematology ·Pierre Loap, Ludovic De Marzi, Carlos Eduardo Almeida, Amelia Barcellini, Julie A. Bradley, Maria Carmen De Santis, R. Dendale, Rachel Jimenez, Ester Orlandi, Youlia Kirova	12
17	An organizational model for female leadership in healthcare. The national centre of oncological hadrontherapy (cnao foundation) experience during the covid-19 pandemic 2021 ·ARCA (Università Ca' Foscari Venezia) ·Paola Verónica Paoloni, Francesca Dal Mas, Michele Massaro, Amelia Barcellini, Ester Orlandi	0
18	Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma 2021 ·Radiotherapy and Oncology ·Stefano Cavalieri, Sara Ronchi, Amelia Barcellini, Maria Bonora, Barbara Vischioni, Viviana Vitolo, (unknown), Michele Del Vecchio, Lisa Licitra, Ester Orlandi	14
19	Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO‐Head and Neck working group 2020 ·Oral Diseases ·Ciro Franzese, Rossana Ingargiola, Stefano Tomatis, Nicola Alessandro Iacovelli, G. Beltramo, Pierfrancesco Franco, Pierluigi Bonomo, (unknown), (unknown), Domenico Cante, (unknown), Daniela Musio, Francesca De Felice, Carlo Furlan, Marta Scorsetti, Ester Orlandi	12
20	Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer 2019 ·Oral Oncology ·Ester Orlandi, Nicola Alessandro Iacovelli, Vincenzo Tombolini, T. Rancati, Antonella Polimeni, Loris De Cecco, R. Valdagni, Francesca De Felice	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact